These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32168821)

  • 21. Benzoic acid-derived nitrones: A new class of potential acetylcholinesterase inhibitors and neuroprotective agents.
    Oliveira C; Bagetta D; Cagide F; Teixeira J; Amorim R; Silva T; Garrido J; Remião F; Uriarte E; Oliveira PJ; Alcaro S; Ortuso F; Borges F
    Eur J Med Chem; 2019 Jul; 174():116-129. PubMed ID: 31029943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pd-Catalyzed Direct Diversification of Natural Anti-Alzheimer's Disease Drug: Synthesis and Biological Evaluation of
    Miao SX; Wan LX; He ZX; Zhou XL; Li X; Gao F
    J Nat Prod; 2021 Aug; 84(8):2374-2379. PubMed ID: 34445873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Pyridine-Containing Sultones: Structure-Activity Relationship and Biological Evaluation as Selective AChE Inhibitors for the Treatment of Alzheimer's disease.
    Zhang H; Wu C; Chen X; Zhang Z; Jiang X; Qin HL; Tang W
    ChemMedChem; 2021 Oct; 16(20):3189-3200. PubMed ID: 34036731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
    Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
    Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, in vitro acetylcholinesterase inhibitory activity and molecular docking of new acridine-coumarin hybrids.
    Hamulakova S; Janovec L; Soukup O; Jun D; Kuca K
    Int J Biol Macromol; 2017 Nov; 104(Pt A):333-338. PubMed ID: 28601645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tuned C-H functionalization to construct aza-podophyllotoxin/aza-conidendrin derivatives by means of domino cyclization.
    Hu Y; Qu Y; Wu F; Gui J; Wei Y; Hu Q; Wang S
    Chem Asian J; 2010 Feb; 5(2):309-14. PubMed ID: 20041457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expeditious construction of a carbobicyclic skeleton via sp3-C-H functionalization: hydride shift from an aliphatic tertiary position in an internal redox process.
    Mori K; Sueoka S; Akiyama T
    J Am Chem Soc; 2011 Mar; 133(8):2424-6. PubMed ID: 21306120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Palladium-Catalyzed Synthesis, Acetylcholinesterase Inhibition, and Neuroprotective Activities of
    Zhang Y; Xu JB; Xiao Y; Ji WS; Shan LH; Wan LX; Zhou XL; Lei Y; Gao F
    J Nat Prod; 2023 Apr; 86(4):939-946. PubMed ID: 36808969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease.
    Amin KM; Abdel Rahman DE; Abdelrasheed Allam H; El-Zoheiry HH
    Bioorg Chem; 2021 May; 110():104792. PubMed ID: 33799178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase.
    Huang L; Luo Z; He F; Lu J; Li X
    Bioorg Med Chem; 2010 Jun; 18(12):4475-84. PubMed ID: 20471843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, in vitro pharmacology, and molecular modeling of syn-huprines as acetylcholinesterase inhibitors.
    Camps P; Gómez E; Muñoz-Torrero D; Badia A; Vivas NM; Barril X; Orozco M; Luque FJ
    J Med Chem; 2001 Dec; 44(26):4733-6. PubMed ID: 11741490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tailored Modeling of Rivastigmine Derivatives as Dual Acetylcholinesterase and Butyrylcholinesterase Inhibitors for Alzheimer's Disease Treatment.
    Adeowo FY; Oyetunji TP; Ejalonibu MA; Ndagi U; Kumalo HM; Lawal MM
    Chem Biodivers; 2021 Nov; 18(11):e2100361. PubMed ID: 34547176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, biological assessment and molecular modeling of 14-aryl-10,11,12,14-tetrahydro-9H-benzo[5,6]chromeno[2,3-b]quinolin-13-amines.
    Maalej E; Chabchoub F; Samadi A; de los Ríos C; Perona A; Morreale A; Marco-Contelles J
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2384-8. PubMed ID: 21411323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and Synthesis of Selective Acetylcholinesterase Inhibitors: Arylisoxazole-Phenylpiperazine Derivatives.
    Saeedi M; Mohtadi-Haghighi D; Mirfazli SS; Mahdavi M; Hariri R; Lotfian H; Edraki N; Iraji A; Firuzi O; Akbarzadeh T
    Chem Biodivers; 2019 Feb; 16(2):e1800433. PubMed ID: 30460743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tertiary amine derivatives of chlorochalcone as acetylcholinesterase (AChE) and buthylcholinesterase (BuChE) inhibitors: the influence of chlorine, alkyl amine side chain and α,β-unsaturated ketone group.
    Gao XH; Zhou C; Liu HR; Liu LB; Tang JJ; Xia XH
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):146-152. PubMed ID: 27801600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and characterization of three pairs of indolediketopiperazine enantiomers containing infrequent N-methoxy substitution from the marine algal-derived endophytic fungus Acrostalagmus luteoalbus TK-43.
    Cao J; Li XM; Meng LH; Konuklugil B; Li X; Li HL; Wang BG
    Bioorg Chem; 2019 Sep; 90():103030. PubMed ID: 31226467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective activity and acetylcholinesterase inhibition of five Amaryllidaceae species: a comparative study.
    Cortes N; Posada-Duque RA; Alvarez R; Alzate F; Berkov S; Cardona-Gómez GP; Osorio E
    Life Sci; 2015 Feb; 122():42-50. PubMed ID: 25529145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of phenserine analogues and evaluation of their cholinesterase inhibitory activities.
    Shinada M; Narumi F; Osada Y; Matsumoto K; Yoshida T; Higuchi K; Kawasaki T; Tanaka H; Satoh M
    Bioorg Med Chem; 2012 Aug; 20(16):4901-14. PubMed ID: 22831800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.
    Rampa A; Bisi A; Valenti P; Recanatini M; Cavalli A; Andrisano V; Cavrini V; Fin L; Buriani A; Giusti P
    J Med Chem; 1998 Oct; 41(21):3976-86. PubMed ID: 9767635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors.
    Mo J; Yang H; Chen T; Li Q; Lin H; Feng F; Liu W; Qu W; Guo Q; Chi H; Chen Y; Sun H
    Bioorg Chem; 2019 Dec; 93():103310. PubMed ID: 31586704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.